Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Johnson and Johnson
Harvard Business School
Express Scripts
Merck

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,105,152

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,105,152 protect, and when does it expire?

Patent 7,105,152 protects PROAIR HFA and is included in one NDA.

This patent has thirty patent family members in twelve countries.

Summary for Patent: 7,105,152
Title:Suspension aerosol formulations
Abstract:Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.
Inventor(s): Schultz; Robert K. (San Diego, CA), Schultz; David W. (St. Paul, MN), Moris; Robert A. (Lino Lakes, MN)
Assignee: 3M Innovative Properties Company (St. Paul, MN)
Application Number:08/455,490
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,105,152
Patent Claim Types:
see list of patent claims
Formulation; Delivery;

Drugs Protected by US Patent 7,105,152

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Teva Branded Pharm PROAIR HFA albuterol sulfate AEROSOL, METERED;INHALATION 021457-001 Oct 29, 2004 BX RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,105,152

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 150296   Start Trial
Austria 204743   Start Trial
Austria 260641   Start Trial
Australia 1234297   Start Trial
Australia 3272893   Start Trial
Australia 675633   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Johnson and Johnson
Express Scripts
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.